G
Last Price
52 Week Range
DKK318.40 - DKK730.00
Next Earnings Date
Feb 27 2026 (Estimate)
Next Earnings Date
Feb 27 2026 (Est.)
Last Price
Market Cap | DKK8.46B |
EV | DKK5.83B |
Shares Outstanding | 16.34M |
Beta | 0.57 |
Industry | Biotechnology |
Analyst Rating | OUTPERFORM |
Analyst Target Price | |
Number of Analysts | 2 |
P/E 2025E | 4.81x |
P/Revenue 2025E | 3.18x |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2025E | 95.90% |
Net Profit Margin 2025E | 66.13% |
ROE 2025E | 132.40% |
ROCE 2024 | -7.85% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Gubra A/S
GUBRA
Sector
Healthcare
Industry
Biotechnology
CEO
Rohrwild, Markus
Employees
275
Website
www.gubra.dkIPO Date
2023-04-04
Headquarters
Hørsholm Kongevej 11B, Horsholm, Capital Region of Denmark, 2970 Denmark
The last closing price of Gubra (GUBRA) is DKK517.50, reflecting a -1.15% change from the prior session. Last updated: December 30, 2025 at 11:02 AM Eastern Time
Review the recent GUBRA stock performance trends:Past 1 Month: Gubra (GUBRA) shares have +5.23%.Past 3 Months: The stock has +32.83%.Past 6 Months: GUBRA shares have +11.24%. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Over the last year, Gubra (GUBRA) has established a 52-week price range between a high of DKK730.00 and a low of DKK318.40. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Gubra (GUBRA) is considered a low volatility stock. It has a beta of 0.57, which means it typically moves 0.57 times as much as the broader market. Over the past 52 weeks, GUBRA has traded within a DKK318.40 – DKK730.00 range. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Based on current GUBRA analyst forecasts and market assumptions, the consensus price target for Gubra (GUBRA) is DKK499.50 for 2027. Relative to the current price of DKK517.50, this implies a potential downside of -3.48%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:43 PM Eastern Time
The current Gubra (GUBRA) market capitalization is approximately DKK8.46B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Gubra's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:43 PM Eastern Time
In the most recently reported quarter, Gubra (GUBRA) generated DKK99.10M in revenue, representing a +36.58% year over year change. For the next quarter, analyst consensus currently expects revenue of approximately DKK64.00M, implying an expected -11.79% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:24 AM Eastern Time
In the most recently reported fiscal year, Gubra (GUBRA) generated net income of DKK-36.50M, compared with DKK-44.52M in the prior fiscal year, representing a +18.03% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of DKK1.76B. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:24 AM Eastern Time
Gubra (GUBRA) is currently scheduled to report its next earnings results on February 26, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:43 PM Eastern Time
In the most recently reported quarter, Gubra (GUBRA) revenue was DKK99.10M, compared with analyst consensus expectations of DKK63.00M, representing a +57.30% revenue surprise versus expectations. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:24 AM Eastern Time
Gubra (GUBRA) does not currently pay a dividend. Over the last twelve months (LTM), the company paid DKK0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:24 AM Eastern Time
Analyst assessments of whether Gubra (GUBRA) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: DKK517.50Consensus price target: DKK499.50Implied return: -3.48% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 2:24 AM Eastern Time
Based on the latest available analyst coverage, Gubra (GUBRA) currently carries a Outperform consensus rating. Analysts' average GUBRA price target is DKK499.50. Relative to the current share price of DKK517.50, this suggests a potential price change of approximately -3.48%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 2:24 AM Eastern Time
Like other publicly traded stocks, Gubra (GUBRA) shares are bought and sold on stock exchanges such as CPSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Gubra (GUBRA) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add GUBRA to your watchlist.
Gubra trades under the ticker symbol GUBRA on the CPSE stock exchange. The ticker GUBRA is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Gubra (GUBRA) employs approximately 275 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Gubra (GUBRA) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Gubra (GUBRA) stock peers based on overlapping products, services, and competitive dynamics:Zealand Pharma (ZEAL) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Gubra.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.